Last updated on January 2020

Effect of Home Rehabilitation on State of Patients With PAH HFREF and IHD

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Effects of Chemotherapy | Memory Problems | Joint Injuries | Habit Reversal | Heart disease | Nerve Injury | Severe Premenstrual Symptom | Infantile Fibrosarcoma | Catheter Complications | Cardiac Ischemia | Cancer Prevention | Stasis Dermatitis | Late Infantile Neuronal Ceroid Lipfuscinsosis | Primary Insulin Hypersecretion | Recurrent Pregnancy Loss | Vascular Diseases | Chronic Pelvic Pain | Dental Filling | Serial Evaluation of Ductal Epithelium | Spinocerebellar Disorders | Spine Athroplasty | Indikation: Diabetes - Typ II | Heart Failure With Reduced Ejection Fraction | Renal Anemia | Surviving Abuse | Ischemic Heart Disease | Functional Dyspepsia | Myopic Macular Degeneration | Pulmonary Hypertension | Anemic Cancer | Partial Medial Meniscectomy | Myocardial Ischemia | Chronic Renal Anemia | Pseudobulbar Affect | Pulmonary Arterial Hypertension | Complicated Grief | Low Testosterone | Mental Disability | Testotoxikose | Open Heart Surgery | Abdominal Surgery | Cancer Treatment | Pelvic Adhesions | Gambling Problems | Cardiac Disease
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • age >18 years
  • informed consent signed by patient to conduct the study
  • no diseases excluding rehabilitation
  • pts with idiopathic, inherited PAH (pulmonary arterial hypertension), or in the course of connective tissue diseases, portal hypertension, congenital heart diseases.
  • PAH confirmed in catheterisation of right side of heart mPAP (mean pulmonary arterial pressure) 25 mmHg, PCWP (pulmonary capillary wedge pressure) 15mmHg.
  • Chronic heart failure - left ventricle ejection fraction <40% in echocardiography, NYHA *New York Health Association) class II-III
  • stable ischaemic heart disease in CCS (Canadian Cardiovascular Society) class II-III

Exclusion Criteria:

  • Other types of pulmonary hypertension
  • COPD (chronic obstructive pulmonary disease), asthma
  • malignancies
  • Acute inflammatory state up to 4 weeks before inclusion to the study
  • Acute coronary syndrome up to 3 months before inclusion to the study
  • Heart failure in NYHA IV class
  • severe anaemia (Hgb <11g/dl for men <10g/dl for women)
  • electrolyte and hormonal disturbances in period of 1 month before inclusion to the study
  • substantial modification of treatment of main disease within last 3 months
  • ischaemic heart disease in CCS class IV
  • Other clinical situations excluding to perform controlled program of rehabilitation

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.